NL
Insider
Nikhil Lalwani
PRESIDENT & CEONikhil Lalwani (PRESIDENT & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $4.3M of ANIP (55,000 sh × $77.57, as filed), executed May 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.1M
shares × price, as filed
Last traded
Sep 15
Filed Sep 16
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $11.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$383K5,400 sh × $71.00
Exec Sep 15
Filed Sep 16 · 4:20 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $401K
5,400 sh × $74.30
Exec Aug 25
Filed Aug 26 · 6:15 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $4.3M
55,000 sh × $77.57
Exec May 11
Filed May 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $4.9M
56,960 sh × $85.93
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $1.9M
33,481 sh across 2 lots
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET